HIV: The benefits of prophylaxis of tuberculosis are confirmed

By Science Daily
10 October, 2017

Long-term follow-up in the ANRS TEMPRANO trial confirms that tuberculosis chemoprophylaxis in HIV-infected people is more than ever relevant in resource-limited countries. This prophylactic use of drugs reduces mortality, even among people taking antiretroviral treatment who have a high CD4+ T cell count. 

 

Read the full article here: https://www.sciencedaily.com/releases/2017/10/171010105315.htm